blog.aids.gov — HIV Policy & Programs. Research. New Media.
HIV Policy & Programs. Research. New Media.
A new animated video provides a brief overview of HIV in the United States and illustrates how improvements along each step of the treatment cascade can help us achieve an AIDS-free generation. We are grateful to Gilead for sharing the video, which debuted last fall at the 2012 U.S. Conference on AIDS , the nation’s…
In advance of the annual U.S. Conference on AIDS (USCA), approximately 150 people gathered in Las Vegas over the weekend for the Summit to End the HIV/AIDS Epidemic in America. The two-day event was organized by the National Minority AIDS Council (NMAC), the host of USCA, and attended by executive directors of community-based organizations from…
This week, we join our colleagues across the Department of Health and Human Services (HHS) in celebrating the work of the HHS-supported community health centers during National Health Center Week. The centers provide preventive and primary care services to more than 20 million Americans every year and are important partners in implementing the National HIV/AIDS…
An often-referenced concept in current conversations about our efforts to address HIV/AIDS in the United States is the so-called “treatment cascade”. This concept is a model being used by Federal, state and local agencies to identify issues and opportunities related to improving the delivery of services to persons living with HIV across the entire continuum…
Last week, the HIV/AIDS Bureau (HAB) of the Health Resources and Services Administration (HRSA) issued a Funding Opportunity Announcement (FOA) that will support between 5 and 10 new Part C programs offering HIV early intervention services (EIS) in areas of the country where the HIV epidemic is increasing, demand for services has increased, and the…
The U.S. Food and Drug Administration (FDA) has three important advisory committee meetings scheduled in May that may impact HIV prevention, detection, and treatment. On May 10, 2012, FDA’s Antiviral Advisory Committee will discuss expanding the indication of Truvada (emtricitabine/tenofovir disoproxil fumarate) tablet, made by Gilead Sciences, Inc., to include use for Pre-Exposure Prophylaxis (PrEP),…
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents released updated Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents last week. Revisions to the October 14, 2011, version of the guidelines include both new sections and key updates to existing sections, including: New section on HIV and the older patient…
